tiprankstipranks
Editas Medicine price target lowered to $5 from $7 at Evercore ISI
PremiumThe FlyEditas Medicine price target lowered to $5 from $7 at Evercore ISI
2M ago
Editas Medicine downgraded to Underweight from Neutral at JPMorgan
Premium
The Fly
Editas Medicine downgraded to Underweight from Neutral at JPMorgan
2M ago
Editas Medicine downgraded to Hold from Buy at JonesResearch
Premium
The Fly
Editas Medicine downgraded to Hold from Buy at JonesResearch
2M ago
Editas Medicine price target lowered to $3 from $5 at Barclays
PremiumThe FlyEditas Medicine price target lowered to $3 from $5 at Barclays
2M ago
Editas Medicine downgraded to Hold from Buy at Truist
Premium
The Fly
Editas Medicine downgraded to Hold from Buy at Truist
2M ago
Editas Medicine downgraded to Hold from Buy at Stifel
Premium
The Fly
Editas Medicine downgraded to Hold from Buy at Stifel
2M ago
Editas Medicine reports updated clinical data from RUBY trial of Reni-cel
PremiumThe FlyEditas Medicine reports updated clinical data from RUBY trial of Reni-cel
2M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
Buy/Sell: Wall Street’s top 10 stock calls this week
Premium
The Fly
Buy/Sell: Wall Street’s top 10 stock calls this week
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100